ISO 13958:2014
血液透析和相关治疗用浓缩液

Concentrates for haemodialysis and related therapies


标准号
ISO 13958:2014
发布
2014年
发布单位
国际标准化组织
当前最新
ISO 13958:2014
 
 
引用标准
IEC 60601-1:2005 IEC 60601-2-16:2012 IEC 61010-1:2010 ISO 11663:2014 ISO 13959:2014 ISO 14971:2007 ISO 15223 AMD 1:2002 ISO 15223 AMD 2:2004 ISO 15223-1:2012 ISO 23500:2014
适用范围
This International Standard specifies minimum requirements for concentrates used for haemodialysis and related therapies. For the purpose of this International Standard, “concentrates” are a mixture of chemicals and water, or chemicals in the form of dry powder or other highly concentrated media, that are delivered to the end user to make dialysis fluid used to perform haemodialysis and related therapies. This International Standard is addressed to the manufacturer of such concentrates. In several instances in this International Standard, it became necessary to address the dialysis fluid, which is made by the end user, to help clarify the requirements for manufacturing concentrates. Because the manufacturer of the concentrate does not have control over the final dialysis fluid, any reference to dialysis fluid is for clarification and is not a requirement of the manufacturer. This International Standard includes concentrates in both liquid and powder forms. Also included are additives, also called spikes, which are chemicals that may be added to the concentrate to increase the concentration of one or more of the existing ions in the concentrate and thus in the final dialysis fluid. This International Standard also gives requirements for equipment used to mix acid and bicarbonate powders into concentrate at the user’s facility. Concentrates prepared from prepackaged salts and water at a dialysis facility for use in that facility are excluded from the scope of this International Standard. Although references to dialysis fluid appear herein, this International Standard does not address dialysis fluid as made by the end user. Also excluded from the scope of this International Standard are requirements for the monitoring frequency of water purity used for the making of dialysis fluid by the dialysis facility. Recommendations from the technical committee responsible for this International Standard for monitoring water quality are contained in fluid regeneration systems that regenerate and recirculate small volumes of the dialysis fluid.

ISO 13958:2014相似标准


推荐

血液透析机的结构原理

其工作原理是:透析浓缩液透析用水经过透析液供给系统配制成合格的透析液,通过血液透析器,与血液监护警报系统引出的病人血液进行溶质弥散、渗透超滤作用;作用后的病人血液通过血液监护警报系统返回病人体内,同时透析用后的液体作为废液由透析液供给系统排出;不断循环往复,从而达到治疗的目的,完成整个透析过程。...

血液透析中心污水处理设备-浩宇

,这部分水中的离子浓度增高,但都来源于自来水......一般来说,水处理机每天将产生十几吨甚至更多的“废水”,其实这部分水要是收集起来,作为“中水”,冲冲厕所洗洗地,那是多么的节约呀......2、透析浓缩液相关的“废水”透析浓缩液配制时,清洗配液或者分装容器后产生的“废水”;未用完的透析浓缩液直接倾倒的“废水”,这部分含有钠、钾、氯、钙、碳酸氢盐、醋酸或枸橼酸等成分,这部分液体的pH值或高或低,但应该...

三家冰醋酸原料药生产企业实施垄断被依法处罚1283万元

三是危害透析患者正常治疗。冰醋酸原料药价格高涨,导致下游药企减产、停产血液透析浓缩液,危害血液透析患者正常治疗。接受反垄断调查后,三家企业已将冰醋酸原料药销售价格恢复至竞争状态,并保障市场正常供应。  当前,我国原料药领域垄断行为时有发生,损害患者医药生产企业合法权益,破坏公平竞争的市场秩序。...

市场监管总局:三家垄断原料药企业罚没1千多万

冰醋酸是生产血液透析浓缩液的主要原料药,价格的大幅上涨直接增加下游生产成本,加重下游药企成本负担。三是危害血液透析患者正常治疗。冰醋酸原料药价格高涨,导致下游药企减产、停产血液透析浓缩液,危害血液透析患者正常治疗。  考虑到当事人在调查过程中能够配合本机关的调查,如实陈述相关事实,积极进行整改且违法行为持续时间较短。...


ISO 13958:2014 中可能用到的仪器设备


谁引用了ISO 13958:2014 更多引用





Copyright ©2007-2022 ANTPEDIA, All Rights Reserved
京ICP备07018254号 京公网安备1101085018 电信与信息服务业务经营许可证:京ICP证110310号